May 7, 2021

IP waiver for COVID-19 vaccines is a misguided and ineffective response to a shared global challenge

IP waiver for COVID-19 vaccines is a misguided and ineffective response to a shared global challenge. In the long run, the waiver proposal undermines the existing vaccine eco-system built in the crisis urgency.
May 6, 2021

EU Industrial Strategy 2020: EuropaBio welcomes increased focus on competitiveness and resilience, driven by innovation and advanced technologies

EuropaBio welcomes the in-depth opinion of the European Group on Ethics on the uses of genome editing and thanks the Group for raising the awareness of a technology which will enable the development of many solutions for healthy people and planet.
May 4, 2021

Kaffe Bueno joins EuropaBio: unlocking coffee’s therapeutic and industrial potential

EuropaBio is delighted to announce that Kaffe Bueno joined the association as a corporate member.
April 29, 2021

EuropaBio on NGT study: A positive step towards delivering innovation

EuropaBio welcomes the in-depth opinion of the European Group on Ethics on the uses of genome editing and thanks the Group for raising the awareness of a technology which will enable the development of many solutions for healthy people and planet.
April 28, 2021

The Lithuanian Biotechnology Association joins EuropaBio: it’s time to put Lithuania on a map of the most biotech savvy nations

EuropaBio is delighted to announce that the Lithuanian Biotechnology Association joins EuropaBio
April 27, 2021

EuropaBio proposes how to increase competitiveness of biotechnology sector in the EU

EuropaBio welcomes the in-depth opinion of the European Group on Ethics on the uses of genome editing and thanks the Group for raising the awareness of a technology which will enable the development of many solutions for healthy people and planet.
April 21, 2021

Health and Life Sciences Cluster Bulgaria joins EuropaBio: AI as enabler of biotech growth

EuropaBio is delighted to announce that Health and Life Sciences Cluster Bulgaria has joined EuropaBio.
April 16, 2021

EuropaBio Response to the Public Consultation on Blood, tissues and cells for medical treatments & therapies

EuropaBio welcomes the in-depth opinion of the European Group on Ethics on the uses of genome editing and thanks the Group for raising the awareness of a technology which will enable the development of many solutions for healthy people and planet.
April 14, 2021

UNION Therapeutics joins EuropaBio: building a pipeline for inflammation and infectious diseases

EuropaBio is delighted to announce that UNION Therapeutics has joined the association as a corporate member.
April 6, 2021

Inscripta joins EuropaBio: delivering global biotechnology advances

EuropaBio is delighted to announce that Inscripta has joined EuropaBio as an associate member.
March 31, 2021

EuropaBio response to the EGE report ‘Ethics of Genome Editing’

EuropaBio welcomes the in-depth opinion of the European Group on Ethics on the uses of genome editing and thanks the Group for raising the awareness of a technology which will enable the development of many solutions for healthy people and planet.
March 29, 2021

Abolis joins the EuropaBio 25th Anniversary in 2021

EuropaBio is delighted to announce that Abolis has joined EuropaBio’s 25th Anniversary Celebration Programme as a sponsor.
March 25, 2021

EuropaBio Statement – Vaccine production scale up: International collaboration remains the key

EuropaBio Statement – Vaccine production scale up: International collaboration remains the key.
March 22, 2021

EuropaBio and P-BIO launch the National Associations Council Summit 2021 – Building on Biotechnology: from vaccines to Economic Growth for Europe

EuropaBio and P-BIO launch the National Associations Council Summit 2021 - Building on Biotechnology: from vaccines to Economic Growth for Europe
March 15, 2021

Abolis joins EuropaBio: Sustainable Bio-Based Products

Abolis joins EuropaBio: Sustainable Bio-Based Products.
Become a member